Harbour Capital Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$414K Buy
+44,630
New +$297K 0.08% 215
2021
Q4
Sell
-9,155
Closed -$1.16M 258
2021
Q3
$1.16M Buy
9,155
+638
+7% +$92.9K 0.31% 88
2021
Q2
$1.42M Buy
8,517
+894
+12% +$145K 0.38% 75
2021
Q1
$1.39M Buy
+7,623
New +$1.77M 0.41% 69
2020
Q4
Sell
-4,560
Closed -$1M 170
2020
Q3
$1M Buy
4,560
+2,098
+85% +$444K 0.37% 79
2020
Q2
$470K Buy
2,462
+302
+14% +$52.9K 0.19% 120
2020
Q1
$335K Buy
+2,160
New +$251K 0.17% 129

Other funds holding TDOC

Harbour Capital Advisors's TDOC Position: Q2 2026 in Review

Harbour Capital Advisors opened a new position in Teladoc Health (TDOC) in Q2 2026: 44,630 shares worth $414K. The stake represents 0.08% of the portfolio and ranks #215 among its holdings. This is a return to the name: Harbour Capital Advisors previously reported a position in TDOC as recently as Q3 2021.

Harbour Capital Advisors first reported a position in TDOC in Q1 2020 and has held it in 7 quarters since. The position peaked at $1.42M in Q2 2021. 40 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Harbour Capital Advisors held 44,630 shares of Teladoc Health worth $414K as of Q2 2026.
  • Teladoc Health was a new Harbour Capital Advisors position in Q2 2026.
  • Teladoc Health made up 0.08% of Harbour Capital Advisors's portfolio in Q2 2026, its #215 holding.
  • Harbour Capital Advisors first reported a position in Teladoc Health in Q1 2020 and has held it in 7 quarters since.
  • Harbour Capital Advisors's Teladoc Health position peaked at $1.42M in Q2 2021.
  • 40 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Harbour Capital Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.